BlackRock cuts voting rights attached to ChemoMetec shares to 14.95%
BLK•BlackRock reduced its voting rights in ChemoMetec to 14.95% on Nov. 2, 2026, below the 15% threshold. Aggregate voting rights remained 15.08% in a Nov. 6 disclosure.
1. Voting rights disclosure
BlackRock reduced its share voting rights in ChemoMetec to 14.95% on Nov. 2, 2026, falling below the 15% threshold. Voting rights through financial instruments increased to 0.13%, while aggregate voting rights remained unchanged at 15.08% in the Nov. 6 disclosure.
